Home › Funds › Vestal Point Capital, LP › AZN

Vestal Point Capital, LP position in AZN

ASTRAZENECA PLC · Health Care

Vestal Point Capital, LP reported holding 450,000 shares of AZN (ASTRAZENECA PLC) in its Q2 2026 13F filing — a position valued at US$85.3M, representing 1.99% of its reported portfolio and ranking #16 among its reported holdings. Vestal Point Capital, LP has disclosed AZN holdings in 5 of the last 11 reported quarters, going back to Q4 2023.

Latest position (Q2 2026)450.00K sh
Reported value held$85.33M
Portfolio Weight1.99%
First reportedQ4 2023
Last changeAdd
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Vestal Point Capital, LP's AZN position evolved

Vestal Point Capital, LP first disclosed a stake in AZN in Q4 2023 at 250,000 shares (US$16.8M). The position peaked in Q2 2026 at 450,000 shares, worth US$85.3M. Across 5 filings, Vestal Point Capital, LP increased the stake 2 time(s), trimmed it 0 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 450,000 shares valued at US$85.3M — an increase of 350,000 shares quarter over quarter.. Notable position changes include a 60% increase in Q1 2024 (shares rose 15% over the following quarter), a 350% increase in Q2 2026 (shares fell 15% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q4 2023 250.00K $16.84M New
Q1 2024 400.00K $27.10M Add
Q4 2024 475.00K $31.12M New
Q1 2026 100.00K $19.72M New
Q2 2026 450.00K $85.33M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About AZN and 13F data

AZN (ASTRAZENECA PLC) is a Health Care company. 71 other funds we track also report a position in AZN — the largest reported positions include Evelyn Partners Group Ltd (US$41.52B), Banque Cantonale Vaudoise (US$11.31B), INVESTOR AB (US$9.78B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding AZN

All AZN fund holders →

FAQ

How long has Vestal Point Capital, LP held AZN?

Vestal Point Capital, LP has disclosed AZN holdings in 5 of the last 11 reported quarters, going back to Q4 2023.

What is Vestal Point Capital, LP's current position in AZN?

As of Q2 2026, Vestal Point Capital, LP holds 450.00K shares of AZN (ASTRAZENECA PLC), valued at $85.33M, representing 1.99% of its reported portfolio and ranking #16.

Has Vestal Point Capital, LP been buying or selling AZN?

In the latest 13F filing (Q2 2026), Vestal Point Capital, LP increased its position in AZN. The position peaked in Q2 2026 at 450.00K shares.

Which other funds hold AZN?

Other major institutional holders of AZN include Evelyn Partners Group Ltd, Banque Cantonale Vaudoise, INVESTOR AB, among 71 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.